Halma plc (LON:HLMA – Get Free Report) reached a new 52-week low on Thursday. The stock traded as low as GBX 3,260 and last traded at GBX 3,264, with a volume of 5,319,404 shares trading hands. The stock had previously closed at GBX 3,480.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on HLMA shares. Berenberg Bank reaffirmed a “buy” rating and set a GBX 4,200 price objective on shares of Halma in a report on Thursday, July 16th. Jefferies Financial Group reiterated a “hold” rating and set a GBX 3,660 target price on shares of Halma in a research report on Friday, September 25th. Five research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of £6,003.71.
Read Our Latest Research Report on Halma
Halma Price Performance
Insider Activity at Halma
In other news, insider Marc Ronchetti sold 47,000 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of GBX 3,813, for a total transaction of £1,792,110. Also, insider Jennifer Ward sold 13,145 shares of the company’s stock in a transaction that occurred on Thursday, July 23rd. The shares were sold at an average price of GBX 3,645, for a total value of £479,135.25. Insiders have sold 62,393 shares of company stock valued at $235,309,493 in the last 90 days. Company insiders own 0.82% of the company’s stock.
Halma Company Profile
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.
Recommended Stories
- Five stocks we like better than Halma
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Halma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halma and related companies with MarketBeat.com's FREE daily email newsletter.
